Eli Lilly and Company (LILY34) — Cash Flow Quality Index
Eli Lilly and Company (LILY34) has a Cash Flow Quality Index of 0.49x as of December 2025. Operating cash flow of R$3.22 Billion is below net income of R$6.64 Billion, suggesting accrual-heavy earnings not yet converted to cash. Explore how efficiently does Eli Lilly and Company generate cash to assess how effectively this company generates cash.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Eli Lilly and Company Cash Flow Quality Index (2014–2025)
Historical Cash Flow Quality Index for Eli Lilly and Company across 11 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check LILY34 capex plus investments ratio to assess the company's total reinvestment commitment from operating cash flow.
Annual Cash Flow Quality Index for Eli Lilly and Company (2014–2025)
Year-by-year earnings quality comparison for Eli Lilly and Company. For live market cap and the full company financial profile, see Eli Lilly and Company stock valuation.
| Year | Quality Index | Operating CF (BRL) | Net Income | YoY Change |
|---|---|---|---|---|
| 2025 | 0.81x | R$16.81 Billion | R$20.64 Billion | ▼ -2.2% |
| 2024 | 0.83x | R$8.82 Billion | R$10.59 Billion | ▼ -23.6% |
| 2023 | 1.09x | R$5.71 Billion | R$5.24 Billion | ▼ -3.9% |
| 2022 | 1.13x | R$7.08 Billion | R$6.24 Billion | ▼ -12.8% |
| 2021 | 1.30x | R$7.26 Billion | R$5.58 Billion | ▲ +24.0% |
| 2020 | 1.05x | R$6.50 Billion | R$6.19 Billion | ▲ +80.5% |
| 2019 | 0.58x | R$4.84 Billion | R$8.32 Billion | ▼ -66.0% |
| 2018 | 1.71x | R$5.52 Billion | R$3.23 Billion | ▼ -3.5% |
| 2016 | 1.77x | R$4.85 Billion | R$2.74 Billion | ▲ +44.0% |
| 2015 | 1.23x | R$2.96 Billion | R$2.41 Billion | ▼ -34.0% |
| 2014 | 1.87x | R$4.46 Billion | R$2.39 Billion | — |